Any documentation referred to in Regulation (EU) 2021/2282 and in this Regulation shall be sent in a digital format and shall be exchanged with and between the Coordination Group, the JSC Subgroup, the HTA Secretariat, the health technology developer and individual experts during joint scientific consultations on medical devices and in vitro diagnostic medical devices through the HTA IT platform.
Art. 15 Regulation (EU) 2025/117
Correspondence during joint scientific consultations
In forcesince 24 Jan 2025